Drägerwerk stock trades at EUR 100.40 as quarterly results near

Drägerwerk reported preliminary third-quarter EBIT of around EUR 48 million on October 14, 2026, down from EUR 56.7 million in the comparable quarter. Net sales rose to around EUR 851 million, while the company confirmed its 2026 forecast. The figures and outlook were published in an EQS News announcement.

At Lang & Schwarz, Drägerwerk stock trades in weekend trading at EUR 100.40 at 5:12 p.m. CEST on October 25, 2026. That is 0.20 percent below the Xetra close of October 23, 2026, at EUR 100.60. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Drägerwerk stock.

The week in figures

The current weekend-trading price is EUR 100.40 against the Xetra close of October 23, 2026, at EUR 100.60. The comparison represents a decline of EUR 0.20, or 0.20 percent.

Chronology of the week

Dräger’s October 14 announcement said third-quarter net sales increased 1.0 percent on a currency-adjusted basis and 2.1 percent nominally. Order intake rose 7.0 percent on a currency-adjusted basis to around EUR 926 million. Dräger also continued to expect currency-adjusted 2026 net-sales growth of 2.0 percent to 6.0 percent and an EBIT margin of 6.0 percent to 8.0 percent. The announcement is available from EQS News.

Dates of the coming week

Dräger is scheduled to publish its quarterly statement for the third quarter of 2026 on October 29, 2026, at 7:30 a.m. CET, followed by a conference call. The date and schedule are listed on the company’s investor-relations calendar.

Market context: Market report DAX.